4//SEC Filing
Muenchbach Martin 4
Accession 0001104659-11-065860
CIK 0001428522other
Filed
Nov 21, 7:00 PM ET
Accepted
Nov 22, 8:06 PM ET
Size
6.2 KB
Accession
0001104659-11-065860
Insider Transaction Report
Form 4
Muenchbach Martin
Director
Transactions
- Award
Series A-1 Convertible Preferred Stock
2011-11-18$81.42/sh+20,470$1,666,667→ 64,066 total(indirect: By Fund)From: 2011-11-18→ Common Stock (204,700 underlying)
Footnotes (2)
- [F1]The Series A-1 convertible preferred stock is convertible into common stock at any time on a one-for-ten basis, and has no expiration date.
- [F2]The reported securities are owned directly by BB Biotech Ventures II L.P. ("BBBV LP"). BB Biotech Ventures GP (Guernsey) Limited ("BBBV Limited") is the General Partner of BBBV LP. The reporting person is a Senior Investment Advisor Private Equity at Bellevue Asset Management AG ("BAM AG") and advises Asset Management BAB N.V. ("AMB NV") who, pursuant to a services agreement with BAM AG, advises the directors of BBBV Limited. The reporting person shares voting and investment power over the BBBV LP shares. The reporting person disclaims beneficial ownership of the securities reported herein except to the extent of his pecuniary interest therein.
Documents
Issuer
Radius Health, Inc.
CIK 0001428522
Entity typeother
Related Parties
1- filerCIK 0001380842
Filing Metadata
- Form type
- 4
- Filed
- Nov 21, 7:00 PM ET
- Accepted
- Nov 22, 8:06 PM ET
- Size
- 6.2 KB